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Abstract
Immune responses in the brain are thought to play a role in disorders of the central nervous 
system, but an understanding of the process underlying how immune cells get into the brain and 
their fate there remains unclear. In this study, we used a 2-photon microscopy to reveal that 
neutrophils infiltrate brain and migrate toward amyloid plaques in a mouse model of Alzheimer’s 
disease. These findings suggest a new molecular process underlying the pathophysiology of 
Alzheimer’s disease.
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1. Introduction
Although the central nervous system has classically been considered a site of immune 
privilege, recent studies have shown that immune cells can infiltrate the brain under certain 
pathologic conditions (Friese et al., 2004; Lucin and Wyss-Coray, 2009). The major 
causative factor of Alzheimer’s disease (AD), beta-amyloid (Aβ), has been shown to be 
associated with brain inflammatory responses and to activate microglia and monocytes 
(Fiala et al., 2007; Hickman and El Khoury, 2013; Krstic and Knuesel, 2013), raising the 
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possibility that immune responses might play a role in the pathophysiology of AD. 
However, it is unknown whether and how innate immune cells are involved in the progress 
of AD (Fortin et al., 2008). Here, we show that neutrophils, which are the most abundant 
type of white blood cell, infiltrate into the brain and migrate to amyloid plaques in a mouse 
model of AD (the 5XFAD mouse). We labeled neutrophils with a Ly6C/G (Gr-1) Alexa 
Fluor 488-conjugated antibody and followed their movements in the 5XFAD mouse with a 
2-photon in vivo imaging technique. Some neutrophils in the blood vessels infiltrated into 
the brain, migrated toward amyloid plaques, and accumulated at the same locations where 
amyloid plaques were found. One pathologic hallmark of AD is the accumulation of senile 
plaques in the brain, and Aβ is their major constituent. Our results showed that chronic Aβ 
deposition attracted neutrophils from the blood vessels in AD animal model mice, 
suggesting that immune cell responses might be involved in the progress of AD. Although 
the role of immune cells that are colocalized with Aβ plaques is unknown, they might be 
involved in the pathology of senile plaques. Understanding this process might provide 
insights into the pathophysiology and potential treatments of AD.
2. Methods
2.1. Animals and surgery
The 5XFAD mice (Tg6799; B6SJL-Tg [APPSwFlLon, PSEN* M146L*L286V] 6799Vas/J, 
stock no. 006554) that were used in this experiment were 9–13 months old and were 
obtained from The Jackson Laboratory (Bar Harbor, ME, USA). These mice express 3 
mutations (Swedish, Florida, and London) of human amyloid precursor protein 695 and 2 
mutations (M146L and L286V) of human presenilin-1 (Oakley et al., 2006). A craniotomy 
surgery was performed as described previously (Mostany and Portera-Cailliau, 2008). 
Briefly, the mice were initially anesthetized with isoflurane, and the hair on the skin of the 
imaging area was removed. Dexamethasone (0.2 mg/kg) and carprofen (5 mg/kg) were 
intramuscularly injected before the surgery to avoid inflammatory responses or swelling of 
the brain. After drilling, a lidocaine and epinephrine mixture was also applied to the 
periosteumto prevent pain or excessive bleeding. A 5-mm round coverslip was placed on top 
of the dura mater with cyanoacrylate-based glue and dental acrylic. The body temperature of 
the mice was maintained with a heating plate (Live Cell Instrument, Seoul, Korea) that was 
set to 37 °C. The animal treatment and maintenance protocols were approved by the Ethics 
Review Committee for Animal Experimentation in Seoul National University.
2.2. Multiphoton imaging
To image the neutrophils, 0.12 mg/kg of the Ly6C/G (Gr-1) Alexa Fluor 488-conjugated 
antibody was intravenously injected through the femoral vein immediately before the 
imaging. Texas red-dextran was also intravenously injected to label the vessels before 
imaging. To visualize amyloid plaques, methoxy-XO4 (5 mg/mL in 10% dimethyl 
sulfoxide, 45% propylene glycol, and 45% saline) was intraperitoneally injected 24 hours 
before the imaging. The multiphoton imaging was performed with a LSM 7 MP 2-photon 
laser scanning microscope system (Carl Zeiss Microscopy GmbH, Oberkochen, Germany). 
The Volocity image analysis software program (PerkinElmer Inc, Waltham, MA, USA) was 
used to process the 3D imaging and track the movements of the neutrophils.
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2.3. Isolation of the mouse neutrophils and the flow cytometry analysis
The neutrophils were isolated from wild-type (WT) and 5XFAD mouse brains. In brief, we 
isolated the brains while the animals were under anesthesia at the age of 8 months and 
collected the frontal cortex. The brains were then homogenized with Hank’s Balanced Salt 
Solution (Welgene, Inc, Daegu, Korea) on ice. The cells were incubated at 37 °C with 
Collagenase D (2.5 mg/mL) for 1 hour. The neutrophils were then isolated with Percoll 
density gradient centrifugation. We rinsed these cells in fluorescence-activated cell sorting 
(FACS) buffer (1% fetal calf serum and 0.1% wt/vol sodium azide) and stained them with 
allophycocyanin-conjugated Ly6G (Gr-1) (1:1000) for 30 minutes on ice. After washing the 
cells in FACS buffer, we analyzed them with a FACSCalibur instrument (BD Biosciences, 
San Jose, CA, USA).
2.4. Fabrication of microfluidic platform
The microfluidic platform was fabricated as described (Cho et al., 2013). Briefly, inversed 
features were made on silicon wafers in multilayers: thicknesses of 5 µm for neutrophil 
migration channels, 10 µm for the entrance zone to the migration channels, 50 µm for all 
other compartments on the network wafer, and all features on the valve control wafer, using 
soft lithographic techniques. A mixture of polydimethylsiloxane (PDMS) and its curing 
agent (SYLGARD 184 A/ B, Dowcorning, Midland, MI, USA) at 10:1 was spun to a 
thickness of 150 µm on the network wafer and poured to the control wafer at a thickness of 
~3 mm. The PDMS replica of network and control layers were peeled off from the wafers 
and then treated with oxygen plasma at 50 mW, 10 ccm, for 35 seconds (PX-250, March 
Plasma Systems, Petersburg, FL, USA) for bonding. The assembled PDMS layers were 
punched for reservoirs, treated with oxygen plasma, and bonded to a glass-bottomed 
UniWell plate (MGB001-1-2-LG, Matrical Bioscience, Spokane, WA, USA). The platforms 
were immediately treated for 30 minutes with human-fibronectin (Sigma-Aldrich, St Louis, 
MO) at 50-µg·mL−1 in distilled water (0.2 µm filter, AM9920, Life Technologies, Grand 
Island, NY, USA). Fibronectin-treated surfaces were then rinsed with sterile distilled water 
and the platform was filled with cell culture medium of Iscove’s Modified Dulbecco’s 
medium (30–2005, ATCC, Manassas, VA, USA) supplemented with 20% fetal bovine 
serum (Sigma-Aldrich, St Louis, MO) and 1% penicillin and/or streptomycin (Life 
Technologies).
2.5. Cell preparation
Human neutrophils were was prepared as described (Cho et al., 2013). Briefly, neutrophils 
were isolated from whole blood with HetaSep and an EasySepHuman Neutrophil 
Enrichment Kit (STEMCELL Technologies, Vancouver, Canada). The cell membrane was 
stained with red fluorescent dye (PKH26PCL, Sigma-Aldrich). The stained neutrophils were 
re-suspended in a culturing medium at a concentration of 20 × 106 cells·mL−1. Ten µL of 
cell suspension were injected into the cell compartment and incubated at 37 °C supplied 
with 5% CO2 for 30 minutes to recover their activities.
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2.6. Chemokine preparation
We dissociated any higher molecular weight of Aβ by dissolving a synthesized clear human 
Aβ, 1–42 (4349-v, Peptide Institute, Inc, Japan) in HFIP and then fully evaporate 
hexafluoroisopropanol (HFIP). The dissociated Aβ was dissolved in dimethyl sulfoxide 
(DMSO) at 1 mg·mL−1 for a monomer form and further diluted in phosphate-buffered saline 
(PBS) at 0.1mg·mL−1. The prepared Aβ monomer was diluted in a neutrophil culturing 
medium at working concentrations and immediately used to minimize aggregation or 
degradation. N-formyl-methyl-leucyl-phenylalanine was diluted in sterile distilled water at 
0.1 mg·mL−1 and further diluted in a culturing medium at a working concentration.
2.7. Time-lapse imaging
To simultaneously image the moving neutrophils in the arrayed 48 platforms, we used an 
automated microscope equipped with a motorized stage (EclipseTi, Nikon Inc, Melville, 
NY, USA) as described (Cho et al., 2013). To image live cells, we used a heated incubating 
stage (LiveCell 05-11-0032 Rev B, Pathology Devices Inc, Westminster, MD, USA), which 
was set at 37.7 °C, 5% CO2, and 85% humidity. The time-lapse imaging was taken every 3 
minutes for 2 hours and in a large-area mode of 2 × 2mm2 using a 4× objective lens.
2.8. Analysis of the cellular motility
Acquired time-lapse images with the NIS Elements (Nikon Inc) were analyzed as described 
(Cho et al., 2013). Briefly, we identified and extracted positions of cells from each image 
automatically by using the open-sourced software, CellProfiler (Broad Institute, Boston, 
MA, USA). Extracted information was processed and analyzed to calculate migration speed 
by using MATLAB (Math-Works, Inc, Natick, MA, USA).
2.9. Antibodies and reagents
The anti-mouse Ly6C/G (Gr-1) Alexa Fluor 488 conjugate and Texas red-dextran (70,000 
molecular weight) were purchased from Life Technologies Corporation (Grand Island, NY, 
USA). Antimouse Ly6G (Gr-1) allophycocyanin was purchased from eBioscience, Inc (San 
Diego, CA, USA). Methoxy XO-4 was synthesized with a protocol that has been described 
in a previous paper (Klunk et al., 2002).
2.10. Statistical analysis
All the data were analyzed by paired t tests with GraphPad Prism version 4.0 (GraphPad 
Software, Inc, La Jolla, CA, USA). p-values less than 0.05 were considered statistically 
significant.
3. Results
To examine the neutrophil movements in AD model animals, Ly6C/G (Gr-1) Alexa Fluor 
488-conjugated antibody, which specifically binds to neutrophils, and Texas red-dextran 
were delivered to the blood circulating system with intravenous injections in craniotomized 
5XFAD mice. Two-photon in vivo imaging showed that the neutrophils were rolling and 
crawling along the lumen of the blood vessels in WT and young 5XFAD mice. In contrast, 
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dynamic extravasation of the neutrophils into the brain parenchyma was detected in the 
brains of 9- to 13-month-old 5XFAD mice, which showed pathologic signs of AD, such as 
massive Aβ plaque accumulation, and this was not seen in the brains of WT mice. In Fig. 1 
and Video 1, the red represents the Texas red-conjugated 70-kDa dextran, which circulated 
in the blood vessel, and the green indicates the Ly6C/G (Gr-1) Alexa Fluor 488-conjugated 
antibody, which labels neutrophils. As shown in the figure, the neutrophils exited the blood 
vessels and moved into the brain parenchyma in 5XFAD mice. The time course for the 
transendothelial migration of the neutrophils showed that the extravasation of the 
neutrophils occurred within 2 minutes and 30 seconds (transendothelial migration of 
neutrophils, Fig. 1A, asterisk). Remarkably, these results showed that the blood neutrophils 
entered the brain parenchyma in the AD model mice. We then examined whether the 
neutrophils were mobile once they entered the brain. The in vivo imaging revealed that the 
neutrophils moved around substantially in the brain parenchyma of 5XFAD mice (Video 2). 
The neutrophils from 5XFAD mice showed a higher migration velocity, displacement, and 
meandering index in the brain parenchyma compared with those of the WT (Fig. 1E and F). 
In contrast, neutrophils were rarely found in the brain parenchyma of the WT animals (Fig. 
1B–D, and Video 7). The FACS analysis showed that the number of Gr-1-positive 
neutrophils was significantly increased in the brains of 5XFAD mice compared with WT 
mice (Fig. 1D, * p < 0.05). These results indicated that the old 5XFAD mice brains 
contained a substantial level of neutrophils, which had vigorous motility in the brain.
Our data also demonstrated that the blood-originated neutrophils did not make random 
movements but migrated towards certain locations within the brain. Twenty-four hours after 
the marker injections, the neutrophils rapidly migrated to and locally accumulated in specific 
areas of the brain. The neutrophils (green), which initially showed random migration outside 
of the blood vessels (red) following the marker injections, were suddenly and massively 
recruited to a specific spot (white circle) (Fig. 2A, Video 3). The neutrophils that were 
traced in Video 3 indicated the recruitment of neutrophils to a certain spot in the 5XFAD 
mice brains, and they showed chemotactic behavior (Fig. 2B and C). Such a clustering of 
neutrophils has never been observed in WT animals. This finding indicated that chronic AD 
pathology can recruit neutrophils into the brain parenchyma. To examine the destination of 
neutrophils that accumulated in certain regions, methoxy-XO4, which detects amyloid 
plaques in the brain (Klunk et al., 2002), was systemically injected into 5XFAD mice. 
Strikingly, we found that most of the neutrophils moved in a highly site-directed manner 
toward specific methoxy-XO4-stained amyloid plaques instead of taking the shortest path 
toward a nearby plaque (Fig. 2D and Videos 4–6). Thus, we found that blood neutrophils 
infiltrated into the brain and migrated to Aβ plaques in a mouse model of AD. Although the 
underlying mechanisms for this observation are currently unclear, Aβ itself might play a role 
in chemotaxis (Joslin et al., 1992; Tiffany et al., 2001). To examine this possibility, we 
evaluated any chemotactic activity of neutrophils by soluble Aβ monomers in a microfluidic 
platform. The platform was composed of gradients of Aβ along migration channels from the 
central compartment filled with cells in buffer solution, a right compartment including Aβ 
solution or chemokines, and a left compartment with the same buffer solution as a negative 
control (Fig. 3). The gradients of soluble Aβ (molecular weight of 4.4 kDa) along the 
channels were estimated to provide the original gradients more than 80% for an hour (Cho et 
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al., 2013) and neutrophil migration was monitored for 2 hours. In the experiments, 
neutrophils did not migrate toward the gradients of soluble Aβ monomers at the 
concentrations corresponding to either physiological (10 pM) or pathological levels (10 
nM). In a positive control, neutrophils migrated persistently in a gradient of N-formyl-
methyl-leucyl-phenylalanine at 100 nM at the speed of 14.0 × 0.6 µm·minute−1, which was 
consistent during the experimental period (Student t test. * p < 0.0001 with respect to no-
chemokine condition), ncell > 100 for each condition. Data represent mean ± standard error 
of the mean. These experiments suggest that soluble Aβ monomer may not be a direct 
chemoattractant for neutrophils. Because there is a close association between neutrophils 
and Aβ plaques (Fig. 2E), however, Aβ plaques must be an important factor in recruiting 
neutrophils from the blood mediated with other cellular interactions.
4. Discussion
How neutrophils migrate and whether they are a protective or detrimental factor will be 
important questions to answer in the understanding of AD pathogenesis, especially in 
relation to brain inflammation. There have been several reports that infiltrated immune cells 
contribute to tissue repair by phagocytosing Aβ (Gate et al., 2010; Lee and Landreth, 2010; 
Rezai-Zadeh et al., 2011). Moreover, a recent study has shown that microglia is effective in 
invading neutrophil granulocytes (Neumann et al., 2008). Collectively, these studies raise 
the possibility that amyloid plaques might be engulfed by activated neutrophils and then 
eliminated by microglia. Alternatively, senile plaque-associated glial cells, such as microglia 
and astrocytes, might secrete chemokines to recruit neutrophils. It is obscure at the moment 
what factors trigger the recruitment of blood neutrophils toward Aβ plaques since Aβ itself 
cannot recruit neutrophils directly as shown in Fig. 3. However, controversial findings 
regarding the toxic properties of infiltrated immune cells in the central nervous system 
diseases have been reported (Halle et al., 2008; Heneka et al., 2013). Although the role of 
infiltrated immune cells in the brain is currently controversial, our results showed for the 
first time the dynamic extravasation and migration of neutrophils to brain amyloid plaques 
with live in vivo imaging. Our results suggested the exciting possibility that immune cells 
interact with senile plaques in the brain, thereby influencing the progress of AD. 
Understanding the interaction between neutrophils and senile plaques might provide new 
insights into the pathophysiology and potential treatments of AD.
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Fig. 1. 
The transendothelial migration of neutrophils from blood vessels into the brain parenchyma 
occurs in 5XFAD mice. The brain of a 5XFAD mouse, which exhibited massive Aβ plaque 
burden and neuronal cell death, was imaged with a 2-photon microscope after craniotomy 
surgery, and the dynamic extravasation of neutrophils into the brain parenchyma was 
detected. Intravenously (i.v.) injected Texas red-conjugated 70-kDa Dextran (red) labels 
brain blood vessels, and the Ly6C/G (Gr-1) Alexa Fluor 488-conjugated antibody (green) 
labels neutrophils. (A) Left: neutrophils in the blood vessels exited the brain parenchyma 
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(transendothelial migration of the neutrophils, asterisk). Right: the different side-view 
images of the transendothelial migration of the same neutrophils (white arrow) from Fig. 
1A, left, were taken at intervals of 30 seconds; 1 unit, 10.96 µm. The in vivo imaging of the 
brain of wild-type ([WT]; B) and 5XFAD (C) mice with Texas red-conjugated 70-kDa 
Dextran (red) and Gr-1 Alexa Fluor 488-conjugated antibody (green). The neutrophils that 
migrated into the brain parenchyma were found in 5XFAD mice but not in WT mice. Scale 
bar, 40 µm. (D) A fluorescence-activated cell sorting analysis also shows that Gr-1-positive 
neutrophils were more abundant in the brain of 5XFAD mice (middle) than in WT mice 
(left). N = 2 per group; the experiments were repeated 4 times; * p < 0.05. (E) The 
populations of tracked neutrophils from the 5XFAD mice (Video 2) and WT mice (Video 8) 
were quantified with respect to their average velocity, displacement rate, and meandering 
index; *** p < 0.0001. (F) In addition, the populations of tracked neutrophils from 5XFAD 
mice (Video 2) and WT mice (Video 8) were also examined with respect to their XY track 
plot, which was relative to their starting position. These quantitative data and plots suggest 
that neutrophils migrated into the brain parenchyma and that they have vigorous behavior 
and movement in 5XFAD mice compared with WT mice. Abbreviation: Aβ, beta-amyloid.
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Fig. 2. 
Neutrophils migrate toward β-amyloid plaques in the 5XFAD mouse brain. (A) The 2-
photon in vivo time series imaging of the 5XFAD mouse brain reveals the interaction 
between transmigrated neutrophils, which seem to be activated, and some spots in the brain 
parenchyma. Neutrophils (green), which moved randomly outside the vessels (red), were 
suddenly and massively recruited to the specific spot (white circle). T1: 10 minutes, 0 
seconds; T2: 28 minutes, 0 seconds; T3: 32 minutes, 30 seconds; T4: 39 minutes, 0 seconds; 
T5: 46 minutes, 0 seconds; and T6: 48 minutes, 30 seconds from Video 3. Scale bar, 20 µm. 
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(B) The traced neutrophils from Video 3 were shown as green color at each time point. This 
tracking data also indicated recruitment of neutrophils in the 5XFAD mouse brain. The 
Volocity software program (PerkinElmer Inc, Waltham, MA, USA) was used. (C) 
Chemotactic effects are expressed by the color index. The blue area indicates less 
chemotactic, while more chemotactic movement is indicated by the red color. The center of 
the circle is represented by a red dot in Fig. 3B at each time point, and the chemotactic 
neutrophils were counted at intervals of 5 µm in the vector states. The Volocity software 
program was used. Neutrophils were recruited to β-amyloid plaques in the cortex of 5XFAD 
mice. To visualize the plaques, methoxy-X04 dye, which can cross the blood-brain barrier 
well, was intraperitoneally (i.p.) injected 24 hours before the imaging. (D) The in vivo time 
series imaging in the brain of a 5XFAD mouse. Gr-1-positive neutrophils are recruited near 
βamyloid plaques (white circle, red), and they stick. T1: 0 minutes, T2: 10 minutes, T3: 20 
minutes, T4: 30 minutes, T5: 40 minutes, and T6: 50 minutes from Video 4; 1 unit, 13.87 
µm. (E) The direct binding of neutrophils to β-amyloid plaques. A neutrophil (arrow) is 
directly bound to the small plaque (red) that is already covered with a few neutrophils. T1: 
45 minutes, 30 seconds; T2: 46 minutes, 0 seconds; T3: 46 minutes, 30 seconds; T4: 47 
minutes, 0 seconds; T5: 47 minutes, 30 seconds; T6: 48 minutes, 0 seconds; T7: 48 minutes, 
30 seconds; and T8: 49 minutes, 0 seconds from Video 5; 1 unit, 4.3 µm.
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Fig. 3. 
Quantification of neutrophil chemotaxis by using a microfluidic platform. The platform is 
composed of a central compartment for cells, both side compartments for 2 different 
conditions, and migration channels connecting the compartments. The cell compartment is 
separated from migration channels by a central valve (default-open) and the migration 
channels are separated from chemokine compartment by 2 side valves (default-closed). 
Neutrophils were stained in a red fluorescence for easy tracking and white migration 
channels are overlaid for visualization after imaging. (A) The photo shows the strong 
chemotactic activity of neutrophils by fMLP 100 nM, which is taken at 28 minutes after 
starting the experiment. (B) On the other hand, Aβ at 10 nM does not induce any chemotatic 
activity on the neutrophils from the observation for 2 hours. Scale bar, 200 µm. 
Abbreviations: Aβ, beta-amyloid; fMLP, N-formyl-methyl-leucyl-phenylalanine.
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